Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$100,645,321
+$15,154,666 QoQ
Shares Held
4,179,623
+37.3% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#100
of 2,837 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $2,708,459,664 across 8 Drug Manufacturers - General names. PFE ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,210,321 | $1,451,695,438 | |
| 2 | ABBV |
AbbVie Inc.
|
1,613,385 | $405,992,201 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,259,422 | $290,335,727 | |
| 4 | AMGN |
Amgen Inc
|
516,533 | $187,046,929 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,197,619 | $151,307,184 | |
| 6 | PFE |
Pfizer Inc
This page
|
4,179,623 | $100,645,321 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,691,386 | $97,457,661 | |
| 8 | BIIB |
Biogen Inc.
|
110,984 | $23,979,203 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,645,321 | 4,179,623 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $85,490,655 | 3,044,539 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $73,235,855 | 2,941,199 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $89,218,831 | 3,501,524 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $109,920,279 | 4,534,665 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $86,710,211 | 3,421,871 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $149,077,720 | 5,619,213 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,484,766 | 465,956 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $137,179,700 | 4,902,777 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $176,537,452 | 6,361,710 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $179,253,392 | 6,226,238 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $198,341,938 | 5,979,558 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $252,377,400 | 6,880,518 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $280,075,231 | 6,864,589 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $385,104,980 | 7,515,710 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $121,689,602 | 2,780,841 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $169,746,948 | 3,237,592 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $176,412,280 | 3,407,616 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $228,617,507 | 3,871,592 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $163,127,811 | 3,792,788 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $155,479,924 | 3,970,376 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $150,162,843 | 4,144,710 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $240,114,685 | 6,523,083 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $272,966,807 | 7,437,795 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $237,917,074 | 7,275,744 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $227,037,951 | 6,955,829 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||